You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 143 No. 7, July 1983 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (91)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Transient Bacteremia Following Endoscopic Injection Sclerotherapy of Esophageal Varices

Daniel S. Camara, MD; Marcia Gruber, RN; Christopher J. Barde, MD; Mario Montes, MD; Joseph A. Caruana, Jr, MD; Raphael S. Chung, MD

Arch Intern Med. 1983;143(7):1350-1352.


Abstract

• The incidence of transient bacteremia following endoscopic injection sclerotherapy of esophageal varices was evaluated in 18 patients subjected to 40 sessions of injection sclerotherapy. Blood cultures were obtained before sclerotherapy and at five minutes, 30 minutes, and 24 hours after sclerotherapy. The injectors as well as the endoscope were cultured before and after the procedure. Blood cultures were positive in two patients after injection scierotherapy (Enterobacter cloacae and Staphylococcus species, coagulase-negative, respectively) for an incidence of 5% of transient bacteremia. Pseudomonas aeruginosa was the most frequent bacteria isolated from the injector after sclerotherapy. We conclude that the incidence of transient bacteremia after sclerotherapy is no higher than routine upper-intestinal endoscopy.

(Arch Intern Med 1983;143:1350-1352)



Author Affiliations

From the Division of Gastroenterology and the Departments of Medicine (Drs Camara and Barde and Ms Gruber), Pathology (Dr Montes), and Surgery (Dr Caruana), Buffalo Veterans Administration Medical Center and the State University of New York at Buffalo; and the Department of Surgery, Upstate New York Medical Center, Syracuse (Dr Chung).


Footnotes

Accepted for publication March 28, 1983.

Reprint requests to Veterans Administration Medical Center, Gastrointestinal Unit, 111G, 3495 Bailey Ave, Buffalo, NY 14215 (Dr Camara).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Oral Disease Burden in Patients Undergoing Prosthetic Heart Valve Implantation
Terezhalmy et al.
Ann. Thorac. Surg. 1997;63:402-404.
ABSTRACT | FULL TEXT  

Current Concepts Review - Prophylactic Use of Antibiotics for Procedures after Total Joint Replacement
DEACON et al.
JBJS 1996;78:1755-70.
FULL TEXT  

Prevention of Infective Endocarditis
Durack
NEJM 1995;332:38-44.
FULL TEXT  

Update in Injection Sclerotherapy of Esophageal Varices
Camara
J Intensive Care Med 1986;1:171-177.
ABSTRACT  

Bacteremia and Injection Sclerotherapy
Camara
Arch Intern Med 1986;146:458-459.
ABSTRACT  

Infectious Complications of Endoscopic Injection Sclerotherapy
Low et al.
Arch Intern Med 1986;146:569-571.
ABSTRACT  

Transient Bacteremia and Endocarditis Prophylaxis
Simon
Arch Intern Med 1984;144:34-35.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1983 American Medical Association. All Rights Reserved.